中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝肾综合征的治疗

蔡卫民 张彬彬

引用本文:
Citation:

肝肾综合征的治疗

详细信息
  • 中图分类号: R5752

  • [1]EckardtKU .Renalfailureinliverdisease[J].IntensiveCareMed, 1999, 25∶5.
    [2] WatanabeM , OzakiT , HirataY , etal.Mechanismforloweringbloodammonialevelsbylactitol[J].JpnJPharmacol, 1995, 4∶369-74.
    [3] GinesP , GuevaraM .Goodnewsforhepatorenalsyndrome[J].Hepatolo gy, 2002, 36 (2) ∶504-506.
    [4] AguillonD , SeguinP , MalledantY .Hepatorenalsyndrome:fromphys iopathologytotreatment[J].AnnFrAnesthReanim, 2003, 1∶30-8.
    [5] LenzK , DrumlW , KleinbergerG , etal.Enhancementofrenalfunctionwithornipressininapatientwithdecompensatedcirrhosis[J].Gut, 1985, 26 (12) ∶1385-6.
    [6] LenzK , HortnaglH , DrumlW , etal.Ornipressininthetreatmentoffunctionalrenalfailureindecompensatedelivercirrhosis[J].Gastroen terology, 1991, 101∶1060.
    [7] GuevaraM , GinesP , FemrdezEG , etal.Reversibilityofhepatorenalsyndromebyprolongedadministrationofornipressinandplasmavolumeexpression[J].Hepatology, 1998, 27∶35.
    [8] HadengueA , Gadao, GiostraE , etal.Terilpressininthetreatmentofhepatorenalsyndrome:Adoubleblindcrossoverstudy[J].Hepatology, 1995, 22 (A236) ∶165.
    [9] HadengueA , GadanoA , MoreauR , etal.Beneficialeffectsofthe2daysadministrationofterlipressininpatientswithcirrhosisandhepatore nalsyndrome[J].JHepatol, 1998, 29∶565.
    [10] OrtegaR , GinesP , UrizJ , etal.Terlipressintherapywithandwithoutalbuminforpatientswithhepatorentalsyndrome:resultsofaprospective, nonrandomizedstudy[J].Hepatology, 2002, 36 (4) ∶941-948.
    [11] SolankiP , ChawlaA , GargR , etal.Beneficialeffectsofterlipressininhepatorenalsyndrome:aprospective, randomizedplacebo-controlledclinicaltrial[J].JGastroenterolHepatol, 2003, 18 (2) ∶152-6.
    [12] KaffyF , BorderieC , ChagneauC , etal.Octreotideinthetreatmentofthehepatorenalsyndromeincirrhoticpatients[J].JHepatol, 1999, 30 (1) ∶174.
    [13] AngeliP , VolpinR , GerundaG , etal.Reversaloftype1hepatorenalsyndromewiththeadministrationofmidodrineandoctreotide[J].Hepatol ogy, 1999, 29 (6) ∶1690-7.
    [14] FeveryJ, Van-CutsemE , NevensF , etal.Reversalofhepatorenalsyndromeinfourpatientsbyperoralmisoprostol (prostaglandinE1ana logue) andalbuminadministration[J].JHepatol, 1990, 11 (2) ∶153-8.
    [15] ClewellJD , Walker-RenardP .Prostaglandinsforthetreatmentofhepatorenalsyndrome[J].AnnPharmacother, 1994, 28 (1) ∶54-5.
    [16] DuvouxC , ZanditenasD , HezodeC , etal.EffectsofnoradrenalinandalbumininpatientswithtypeⅠhepatorenalsyndrome:apilotstudy[J].2002, 36 (2) ∶374-380.
    [17] CapellaGL .Anti-leukotrienedrugsinthepreventionandtreatmentofhepatorenalsyndrome[J].ProstaglandinsLeukotEssentFattyAcids, 2003, 68 (4) ∶263-5.
  • 加载中
计量
  • 文章访问数:  2081
  • HTML全文浏览量:  3
  • PDF下载量:  800
  • 被引次数: 0
出版历程
  • 出版日期:  2004-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回